The efficacy of intermittent scanning continuous glucose monitoring in the elderly: A case–control study
Authors' conclusion
The use of is-CGM improves glycemic control in elderly (≥60 years old) persons with DM after 3 months, and this persists for at least 24 months. The number of discontinuations is low. This data emphasizes the positive impact of is-CGM on the elderly population with DM.
Study context
- Population
- Elderly people with type 1 or type 2 diabetes mellitus (DM) aged ≥60 years, DM outpatient clinic of the University Medical Center Groningen, 2015–2022353 analysed
- Participants
- 142 vs 211
- Comparison
- Intermittently scanning continuous glucose monitoring (is-CGM) initiation vs no CGM usage
- Casesn = 142
- Controlsn = 211reference
- Outcome
- HbA1c (glycemic control) after is-CGM initiation
Methodological detailsobservational, matched on age, gender, DM type and treatment type (insulin-pen or pump)
- Observational
- Matched on age, gender, DM type and treatment type (insulin-pen or pump)
Main finding
As reported in the abstract
HbA1c reduction, unadjusted · 3 months after initialization
Cases
−0.50
%
Controls
−0.02
%
P = 0.016
Observational data: associations, not effects.
Further findings
HbA1c at baseline
| Outcome | % | P value |
|---|---|---|
| HbA1c change, adjusted for confounders · 6 monthsSignificant HbA1c reduction with is-CGM initiation · adjusted for confounders | −0.29 | P = 0.006 |
| HbA1c change, adjusted for confounders · 24 monthsSignificant HbA1c reduction with is-CGM initiation · adjusted for confounders | −0.39 | P = 0.033 |
Sensor discontinuation
- Rate of sensor discontinuation
- 2.8%
Original publication
The efficacy of intermittent scanning continuous glucose monitoring in the elderly: A case–control study. Diabetes Obes Metab. Published 13 May 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →